Session 41

 

Monday, September 4
4:15 – 6:15 pm

Room 2

 

 

Endoscopic treatments – Stenting

 

Chairs: George Triadafilopoulos (USA) – Kulwinder Dua (USA)

Discussants:  Ingo F. Herrmann (Germany)

 

• Deep throat: What are the current techniques and outcomes of endoscopic management of Zenker’s diverticulum?
  Ingo F. Herrmann (Germany)                                                             
  Address the indications, techniques and outcomes of endoscopic management for Zenker’s.
• Up in the air: Is balloon dilation still useful in the treatment of achalasia? Joel E. Richter (USA)
  Is balloon dilation better or worse than Heller or POEM? Should it be used only for failures?    
• On the cutting edge: Is ESD the procedure of choice in esophageal dysplasia? Roger P. Tatum (USA)
  Discuss the strengths and weaknesses of ESD in this setting and address if ablation is preferable.      
• Freezing temperatures: Is cryoballoon ablation safe and effective for squamous dysplasia? Marcia Canto (USA)
  Discuss the strengths and weaknesses of cryo-balloon in this setting and address if cryo-ablation is preferable to resection.
• A new standard: What are the long-term outcomes of radiofrequency ablation for dysplastic Barrett’s esophagus?Patrick S. Yachimski (USA)
  Address the long-term efficacy of RFA for Barrett’s dysplasia and the need for ongoing surveillance.

• Cut throat: Can endoscopic resection for Barrett’s dysplasia and early cancer be curative?
  George Triadafilopoulos (USA)
  Discuss the long-term outcomes for mucosal resection for dysplasia and early cancer and compare them to esophagectomy.
• Controlling the tides: How effective is transoral fundoplication for volume acid reflux?
  Pier Alberto Testoni (Italy)
  Specifically discuss the role of TF in the management of regurgitation as a distinct endpoint.
• Stretta to the rescue: Is radiofrequency treatment useful in the management of the postoperative bariatric patient with GERD? Hiroshi Mashimo (USA)
  Address the role of Stretta in the bariatric patient with GERD, if any.
• Cut it out: How promising is anti-reflux mucosectomy for GERD? Vivien Wong (China)
• Technique, safety and outcomes of this new endoscopic method for GERD.
• Music to our ears: How safe and effective is MUSE endoscopic anterior fundoplication?
  Johannes Zacherl (Austria)                                                             
  Update on this endoscopic modality and long-term data in GERD.        

• Buying time: What is the efficacy of stenting for benign esophageal strictures? Kulwinder S. Dua (USA) 
  Discuss the technicalities and potential of temporary stenting in benign esophageal disease.
• To stent or not to stent: What are the choices for endoscopic palliation of malignant esophageal strictures?
  Russell E. White (Kenya)                                                                                                                                           
  What non-stent options do we have in the palliation of esophageal cancer? How do they compare to stents?
• Scary tears: When and how should we dilate the esophagus in EoE? Joel E. Richter (USA)  
  Technicalities and outcomes of dilation for EoE.

• Combining forces: When is dual (or triple) therapy preferred in Barrett’s dysplasia? Marmy Shah (USA)
  Ablation? Resection? +/- PPI? +/- fundoplication? +/- cryotherapy?   
• Poetry in action: What are the strengths and weaknesses of POEM for achalasia?
  Lee L. Swanström (USA-France)
  Technicalities on POEM and update on its outcomes.